The sleep-promoting and hypothermic effects of glycine are mediated by NMDA receptors in the suprachiasmatic nucleus.
Level 5 - mechanism / opinion, no new human data
Preclinical animal/laboratory study (in vivo rat model)
PubMed 25533534 · doi:10.1038/npp.2014.326
What was done
Researchers evaluated the mechanisms and neuroanatomical site of action of glycine on sleep and thermoregulation in rats. They tested oral and intracerebroventricular administration of glycine during acute sleep disturbance, tracking non-rapid eye movement (NREM) sleep latency, sleep architecture, core body temperature, and plantar cutaneous blood flow (CBF). They examined pharmacological blockade of NMDA receptors (AP5, CGP78608, L-701324) and glycine receptors (strychnine), tracked hypothalamic c-Fos expression, performed targeted microinjections of glycine and D-serine into specific hypothalamic nuclei (suprachiasmatic nucleus [SCN], medial preoptic area [MPO], dorsal subparaventricular zone), and tested the effects of SCN ablation.
What was found
The abstract reports directional and dose-dependent outcomes without numeric values or effect sizes. Oral glycine shortened NREM sleep latency and induced NREM sleep alongside decreased core body temperature. Both oral and central administration dose-dependently increased plantar CBF to facilitate heat loss. The CBF increase was blocked by NMDA receptor antagonists (AP5 and CGP78608) but not by the glycine receptor antagonist strychnine. Glycine induced c-Fos expression in the MPO and SCN shell. Direct microinjection of glycine or D-serine into the SCN shell (but not MPO or dorsal subparaventricular zone) increased CBF in a dose-dependent manner; this effect was blocked by L-701324. Surgical SCN ablation completely abolished glycine's hypothermic and sleep-promoting effects.
Why it matters
This study delineates the central mechanism for glycine-induced sleep enhancement, showing it acts via SCN shell NMDA receptors to induce peripheral vasodilation and heat loss rather than through classic strychnine-sensitive glycine receptors.
Limits
Findings are entirely derived from rat models and cannot directly establish human clinical parameters. Specific sample sizes, variance, and exact quantitative changes are not reported in the abstract. The study examined acute sleep disturbance rather than chronic insomnia.
Cited by
- partial Therapeutic doses of glycine contribute significantly to promoting deep sleep.